Rie Igarashi

3.2k total citations
72 papers, 1.6k citations indexed

About

Rie Igarashi is a scholar working on Molecular Biology, Pharmaceutical Science and Pathology and Forensic Medicine. According to data from OpenAlex, Rie Igarashi has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Pharmaceutical Science and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Rie Igarashi's work include Advanced Drug Delivery Systems (8 papers), Vitamin C and Antioxidants Research (6 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Rie Igarashi is often cited by papers focused on Advanced Drug Delivery Systems (8 papers), Vitamin C and Antioxidants Research (6 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Rie Igarashi collaborates with scholars based in Japan, United States and Belgium. Rie Igarashi's co-authors include Mitsuko Takenaga, Yutaka Mizushima, Yuji Yamaguchi, Yoshitomi Morizawa, Shinichi Kawai, Yuki Ohta, Yuriko Ogawa, Fumiyoshi Yamashita, Mitsuru Hashida and Shigeru Kawakami and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Rie Igarashi

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rie Igarashi Japan 22 576 355 293 224 193 72 1.6k
Mitsuko Takenaga Japan 22 533 0.9× 350 1.0× 333 1.1× 166 0.7× 212 1.1× 67 1.6k
Lingyun Sun China 25 447 0.8× 238 0.7× 144 0.5× 476 2.1× 67 0.3× 96 1.8k
Mohammed Inayathullah United States 26 587 1.0× 129 0.4× 305 1.0× 150 0.7× 205 1.1× 54 2.0k
Yuefeng Rao China 20 480 0.8× 541 1.5× 321 1.1× 139 0.6× 111 0.6× 51 1.7k
Megumu Higaki Japan 25 307 0.5× 194 0.5× 220 0.8× 322 1.4× 76 0.4× 48 1.5k
Hedwig S. Murphy United States 21 506 0.9× 98 0.3× 201 0.7× 464 2.1× 265 1.4× 32 1.8k
Takahiro Morita Japan 21 403 0.7× 346 1.0× 169 0.6× 77 0.3× 160 0.8× 58 1.2k
Casimiro Luca Gigliotti Italy 26 573 1.0× 269 0.8× 446 1.5× 401 1.8× 63 0.3× 53 1.8k
Wei-Chun Chang Taiwan 22 732 1.3× 189 0.5× 141 0.5× 172 0.8× 89 0.5× 60 2.1k
Houyuan Hu China 21 578 1.0× 136 0.4× 339 1.2× 313 1.4× 220 1.1× 44 1.8k

Countries citing papers authored by Rie Igarashi

Since Specialization
Citations

This map shows the geographic impact of Rie Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rie Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rie Igarashi more than expected).

Fields of papers citing papers by Rie Igarashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rie Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rie Igarashi. The network helps show where Rie Igarashi may publish in the future.

Co-authorship network of co-authors of Rie Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Rie Igarashi. A scholar is included among the top collaborators of Rie Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rie Igarashi. Rie Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tanaka, Kazunori, Yoshiki Kubota, Kiyoshi Higashi, et al.. (2023). Expression of Epithelial–Mesenchymal Transition Markers in Epidermal Layer of Atopic Dermatitis. Biological and Pharmaceutical Bulletin. 47(1). 49–59. 4 indexed citations
3.
Fujita, Hidetoshi, et al.. (2023). Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A phase III study (V114-033). Vaccine. 41(34). 4933–4940. 3 indexed citations
4.
Takenaga, Mitsuko & Rie Igarashi. (2009). Lipo prostaglandin E1. Drug Delivery System. 24(4). 408–414. 1 indexed citations
5.
Maeda, Taishi, Tsutomu Ishihara, Haruka Sakamoto, et al.. (2009). Synthesis of Prostaglandin E1 Phosphate Derivatives and Their Encapsulation in Biodegradable Nanoparticles. Pharmaceutical Research. 26(7). 1792–1800. 11 indexed citations
6.
Ishihara, Tomoaki, Ken‐ichiro Tanaka, Yuichi Tasaka, et al.. (2008). Therapeutic Effect of Lecithinized Superoxide Dismutase against Colitis. Journal of Pharmacology and Experimental Therapeutics. 328(1). 152–164. 81 indexed citations
7.
Wijagkanalan, Wassana, Shigeru Kawakami, Mitsuko Takenaga, et al.. (2007). Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. Journal of Controlled Release. 125(2). 121–130. 129 indexed citations
8.
Kojima, Fumiaki, et al.. (2005). Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukotrienes and Essential Fatty Acids. 73(2). 103–111. 36 indexed citations
9.
Takenaga, Mitsuko, Hirokazu Tamamura, Kenichi Hiramatsu, et al.. (2004). A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma. Biochemical and Biophysical Research Communications. 320(1). 226–232. 81 indexed citations
10.
Igarashi, Rie, Mitsuko Takenaga, Yoko Yamaguchi, et al.. (2004). Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation. Journal of Controlled Release. 102(2). 463–473. 1 indexed citations
11.
Igarashi, Rie, et al.. (2003). Worldwide development of lipo-PGE1. Drug Delivery System. 18(5). 426–430. 1 indexed citations
12.
Igarashi, Rie. (2003). Porcine enamel matrix derivative enhances the formation of reparative dentine and dentine bridges during wound healing of amputated rat molars. Journal of Electron Microscopy. 52(>2). 227–236. 25 indexed citations
13.
Ishizaka, Nobukazu, Junichi Taguchi, Johbu Itoh, et al.. (2000). Lecithinized copper, zinc-superoxide dismutase ameliorates prolonged hypoxia-induced injury of cardiomyocytes. Free Radical Biology and Medicine. 29(1). 34–41. 11 indexed citations
14.
Takenaga, Mitsuko, et al.. (2000). Effect of a soluble pseudo-receptor on verotoxin 2-induced toxicity. Journal of Infection and Chemotherapy. 6(1). 21–25. 4 indexed citations
15.
Takenaga, Mitsuko, Rie Igarashi, Kayo Matsumoto, et al.. (1999). Lipid Microsphere Preparation of a Lipophilic Ceramide Derivative Suppresses Colony Formation in a Murine Experimental Pulmonary Metastasis Model. Journal of drug targeting. 7(3). 187–195. 3 indexed citations
16.
Ikeda, Yoko, Manae S. Kurokawa, Kayo Masuko, et al.. (1996). CHARACTERIZATION OF T CELL RECEPTOR ?? CHAINS OF ACCUMULATING T CELLS IN SKIN ALLOGRAFTS IN MICE1. Transplantation. 62(2). 266–272. 10 indexed citations
17.
Takenaga, Mitsuko, Rie Igarashi, Hiroaki Tsuji, & Yutaka Mizushima. (1993). Enhanced Antitumor Activity and Reduced Toxicity of 1,3‐Bis(2‐chloroethyl)‐1‐nitrosourea Administered in Lipid Microspheres to Tumor‐bearing Mice. Japanese Journal of Cancer Research. 84(10). 1078–1085. 13 indexed citations
18.
Takenaga, Mitsuko, et al.. (1993). Application of Lipid Microspheres to Prepare a Thromboxane A2Receptor Antagonist Aerosol for Inhalation. Journal of drug targeting. 1(4). 293–301. 7 indexed citations
19.
Igarashi, Rie, et al.. (1988). Biological activity of several esterified PGE1 and the application of them to lipid microsphere(LM) preparations.. Ensho. 8(3). 243–246. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026